1-3 of 3
Maureen Hougham
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Plerixafor Plus G-CSF Compared to Chemotherapy Plus G-CSF for Mobilization of Autologous CD34+ Cells Resulted in Similar Cost but More Predictable Days of Apheresis and Less Hospitalization.

Paul Shaughnessy, MD, Miguel Islas-Ohlmayer, MD, Julie Murphy, Maureen Hougham, RN, Jill MacPherson, FNP, Kurt Winkler, PharmD, Matthew Silva, PharmD, Michael Steinberg, PharmD, Jeffrey Matous, MD, Sheryl Selvey, PharmD, Michael Maris, MD, Peter A. McSweeney, MD
Journal: Blood
Blood (2009) 114 (22): 2277.
https://doi.org/10.1182/blood.V114.22.2277.2277
Published: 2009
Journal Articles

Cost Analysis of Mobilization and Autologous Transplantation in Patients Who Received AMD 3100 after Failing Standard Mobilization.

Elina Delgado, Charles F. LeMaistre, MD, Carlos Bachier, Brad Smith, PhD, Guillermo López-González, Maureen Hougham, Shawn Kaleel, Paul Shaughnessy, MD
Journal: Blood
Blood (2008) 112 (11): 2151.
https://doi.org/10.1182/blood.V112.11.2151.2151
Published: 2008
Journal Articles

Once Daily Busulfan and Fludarabine Is Well Tolerated and Effective in Older Heavily Treated Patients Prior to Unrelated Donor Allogeneic Peripheral Blood Stem Cell Transplant.

Grant W. Potter, Carlos Bachier, MD, Brad Smith, PhD, Maureen Hougham, C.F. LeMaistre, MD, Paul J. Shaughnessy, MD
Journal: Blood
Blood (2007) 110 (11): 4950.
https://doi.org/10.1182/blood.V110.11.4950.4950
Published: 2007